Impaired sequence learning in carriers of the DYT1 dystonia mutation

Previous positron emission tomography (PET) studies have shown that nonmanifesting carriers of the DYT1 dystonia mutation express an abnormal pattern of resting glucose metabolism. To determine whether motor behavior is impaired in these subjects, we compared movement and sequence learning in 12 cli...

Full description

Saved in:
Bibliographic Details
Published inAnnals of neurology Vol. 54; no. 1; pp. 102 - 109
Main Authors Ghilardi, Maria-Felice, Carbon, Maren, Silvestri, Giulia, Dhawan, Vijay, Tagliati, Michele, Bressman, Susan, Ghez, Claude, Eidelberg, David
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.07.2003
Willey-Liss
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Previous positron emission tomography (PET) studies have shown that nonmanifesting carriers of the DYT1 dystonia mutation express an abnormal pattern of resting glucose metabolism. To determine whether motor behavior is impaired in these subjects, we compared movement and sequence learning in 12 clinically unaffected DYT1 carriers with 12 age‐matched controls. Regional differences in brain function during task performance were assessed with simultaneous H215O/PET. We found that motor performance was similar in the DYT1 and control groups, with no significant differences in movement time and spatial accuracy measured during each of the tasks. In contrast, sequence learning was reduced in gene carriers relative to controls (p < 0.01). PET imaging during motor execution showed increased activation in gene carriers (p < 0.001, uncorrected) in the left premotor cortex and right supplementary motor area, with concomitant reduction in the posterior medial cerebellum. During sequence learning, activation responses in DYT1 carriers were increased in the left ventral prefrontal cortex, and lateral cerebellum. These findings suggest that abnormalities in motor behavior and brain function exist in clinically nonmanifesting DYT1 carriers. Although localized increases in neural activity may enable normal movement execution in these subjects, this mechanism may not compensate for their defect in sequence learning. Ann Neurol 2003;54:102–109
Bibliography:ark:/67375/WNG-GG3HV4DZ-3
Dystonia Medical Research Foundation
ArticleID:ANA10610
National Institutes of Health - No. NIH RO1 NS 37564; No. NIH KO8 NS 01961; No. NIH K24 NS 02101
istex:D91603D06BD8EC997CC4F44F04A5DACF0A9D58A7
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0364-5134
1531-8249
DOI:10.1002/ana.10610